US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avid Bioservices, Inc.

12.49

+0.0000

Volume:- -

Turnover:38.32M

Market Cap:798.90M

PE:-5.22

High:12.49

Open:12.49

Low:12.49

Close:12.49

Loading ...

Overview Company News Filings

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Press Release: Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Preliminary results for the year ended 31 December 2024

Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward

FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…

Zacks Small Cap Research

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Made in Australia: ASX firms boosting local health and medical manufacturing

Availability of the 2024 Universal Registration Document, including the Annual Financial Report

Lantheus Completes Acquisition of Evergreen Theragnostics

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

CVKD: Preparing for Phase 3 Trial of Tecarfarin…

Zacks Small Cap Research

Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy

OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category

Press Release: Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Samsung Biologics Likely to Benefit From Rising CDMO Penetration -- Market Talk

Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering

Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDMO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"Halted","change":0,"latestTime":"02-04 16:00:00 EST","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528206837","title":"Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528206837","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528206837?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., April 16, 2025  -- Lifecore Biomedical, Inc.   a fully integrated contract development and manufacturing organization , today announced that Lifecore granted a restricted stock unit  award with respect to 45,000 shares of its common stock, an option for 210,000 shares of stock, an RSU for 170,000 shares of common stock, and a performance stock unit  award for up to 370,000 shares of its common stock to Thomas D. Salus, Lifecore’s newly hired chief legal and administration officer. The RSU awards, stock option and PSU award were granted April 14, 2025, pursuant to an employment agreement between Lifecore and Mr. Salus, and as a material inducement to Mr. Salus joining Lifecore as its chief legal and administration officer.About Lifecore BiomedicalLifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical product","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-announces-inducement-grants-under-200500441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","LU2095319765.USD","BK4212","LU2210149790.SGD","NDAQ","CDMO","BK4139","BK4112","IE00BKPKM429.USD","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","IE00B64PRP62.GBP",".IXIC","LU2210150020.SGD","LFCR","CFO"],"gpt_icon":0},{"id":"2527302381","title":"Press Release: Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527302381","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527302381?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry. Significantly Elevates Lifecore's Capabilities Across Corporate Governance, Transactional Activities, and SEC Reporting and Compliance. \"Tom's appointment is the latest action by Lifecore to strengthen our organization by adding top-tier talent to our leadership team. Having in-house counsel will be particularly valuable to drive corporate governance and SEC/Nasdaq reporting and compliance as we continue to streamline the processes that impact performance in these areas,\" said Paul Josephs, president and chief executive officer of Lifecore. \"We are excited to bring Tom on board and benefit from his wealth of experience, particularly his deep ex","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4212","CDMO","NQmain","BK4139","LFCR"],"gpt_icon":0},{"id":"2526352564","title":"Preliminary results for the year ended 31 December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352564","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352564?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196400,"startTime":"0","endTime":"0","summary":"~ Strong commercial momentum underpins transformative financial performance ~ Strong 2024 financial performance in line with guidance Revenue growth of 44% to 128.8 million compared to 2023, organic r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058256/0/en/Preliminary-results-for-the-year-ended-31-December-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4019","BK4139","BK4229","BK4159","CFO","CAGR","AGM","CET","CDMO","ESGR","BK4195","NCI","BK4202"],"gpt_icon":0},{"id":"2525946268","title":"Asahi Kasei Establishes Asahi Kasei Life Science to Drive its Bioprocess Businesses Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=2525946268","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525946268?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115400,"startTime":"0","endTime":"0","summary":"Serving as a premium partner for pharmaceutical companies by contributing to the safety and productivity of their manufacturing process. TOKYO & NOVI, Mich., & DSSELDORF, Germany, April 08, 2025----To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure. Through this change, the company can offer the industry more agile and focused services, deeper innovation in bioprocess solutions, and stronger support in emerging modalities.\"I am thrilled to announce the start of operations at Asahi Kasei Life Science, which began on April 1,\" said Ken Shinomiya, President of Asahi Kasei Life Science. \"Focused on the field of life science centered on the bioprocess business, we aim to expand as part of the growing Healthcare sector business, the main growth driver of the Asahi Kasei Group. As a trusted premium","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asahi-kasei-establishes-asahi-kasei-123000841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4090","BK4139","BK4202","CDMO","AHKSY","BK4145","AHKSF","FORD"],"gpt_icon":0},{"id":"2524902992","title":"FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524902992","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524902992?lang=en_us&edition=fundamental","pubTime":"2025-04-03 23:31","pubTimestamp":1743694260,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc.  is continuing preparations for a Phase 1/2 trial of CYWC628, a fibroblast-based spheroid product candidate, in patients suffering from diabetic foot ulcers , which we anticipate initiating in the second quarter of 2025 and completing before the end of 2025. Recent activities the company has accomplished to support the upcoming clinical trial include:. The company does not utilize single cell fibroblasts for treatment but instead a fibroblast spheroid, which is composed of approximately 3,000 fibroblasts and is administered to the top of the wound at which time the cells migrate from the surface of the wound and release various cytokines and growth factors to initiate the wound healing process. The use of spheroids is more practical from a therapeutic perspective as they have higher viability than single cells, they don’t require pre-culturing before administra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fblg-phase-1-2-trial-153100735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SEPA","BK4139","EAE","CDMO","FBLG"],"gpt_icon":0},{"id":"2524444886","title":"Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2524444886","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524444886?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"PLANO, Texas, April 02, 2025  -- Integer Holdings Corporation  , a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028  that the Notes are convertible, at the option of the holders  beginning on April1, 2025, and ending at the close of business on June30, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company’s common stock or a combination thereof, at the Company’s election, in respect of the remainder, if any, of the Company’s conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/integer-holdings-corporation-announces-conversion-200500630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1169590202.USD","LU1815336091.USD","LU0757428866.USD","LU1559883803.SGD","BK4082","LU0566484027.USD","CDMO","LU0128526141.USD","LU1169589451.USD","LU0029874061.USD","BK4139","ITGR"],"gpt_icon":0},{"id":"2524296891","title":"Made in Australia: ASX firms boosting local health and medical manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524296891","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524296891?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:55","pubTimestamp":1743540941,"startTime":"0","endTime":"0","summary":"Healthcare and medical manufacturing in Australia is gaining momentum supported by initiatives from federal and state governments. CSL, IDT Australia, Optiscan and Trajan Group among healthcare companies with manufacturing facilities in Melbourne. EZZ Life Science said manufacturing in Australia is one of its “biggest selling points” into China and Southeast Asia","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-2201248024-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-2201248024-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/made-in-australia-asx-firms-boosting-local-health-and-medical-manufacturing/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4213","CDMO","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU1023059063.AUD","LU1894683348.USD","BK4599","TGA","LU0058720904.USD","SG9999001176.USD","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","BK4007","LU0225771236.USD","IE00BLSP4452.SGD","LU0321505868.SGD","SG9999002232.USD","LU1066053197.SGD","LU0985481810.HKD","SG9999001176.SGD","SG9999011175.SGD","LU0306807586.USD","BK4550","BK4534","BK4568","BK4592","LU0868494617.USD","LU1894683264.USD","LU0122379950.USD","BK4139","BK4585","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","SG9999003800.SGD","LU1883839398.USD","LU0234572021.USD","LU1066051498.USD","LU0289739699.SGD","SGXZ57979304.SGD","IE0002270589.USD","SG9999002224.SGD","SG9999013999.USD","BK4581","BK4533","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2524149124","title":"Availability of the 2024 Universal Registration Document, including the Annual Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2524149124","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524149124?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:39","pubTimestamp":1743521940,"startTime":"0","endTime":"0","summary":"Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers  on April 1, 2025.The 2024 Universal Registration Document contains in particular:. The annual financial report, including the management report that encompasses namely the Corporate Governance report, the sustainability statement and the company and consolidated statements;The statutory auditors’ reports, including the special report on the regulated agreements;The disclosures relating to statutory auditors’ fees; and. The disclosures relating to the description of the share buy-back program.About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/availability-2024-universal-registration-document-153900821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UVV","CDMO","EAPIF","BK4075","BK4139","BK4007"],"gpt_icon":0},{"id":"2524811984","title":"Lantheus Completes Acquisition of Evergreen Theragnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2524811984","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524811984?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:00","pubTimestamp":1743512400,"startTime":"0","endTime":"0","summary":"Through the transaction, Lantheus has acquired OCTEVY, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors, which complements Lantheus’ therapeutic candidate PNT2003, as well as a portfolio of clinical and pre-clinical theranostic pairs. The acquisition also advances Lantheus’ capabilities with the addition of Evergreen’s radioligand therapy manufacturing infrastructure, including a revenue-generating CDMO business.This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject to risks and uncertainties and are made pursuan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lantheus-completes-acquisition-evergreen-theragnostics-130000370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4198","BK4585","BK4139","LNTH","BK4588","CDMO"],"gpt_icon":0},{"id":"2524594972","title":"BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524594972","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524594972?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million. CDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based Sweeteners. Rehovot, Israel-- - BioHarvest Sciences Inc.   , a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024.Total revenues for the fourth quarter of 2024 increased 62% year-over-year to $7.3 million, exceeding prior management guidance, with gross margins expanding by 600 basis points to 57% of revenue.Ilan Sobel, CEO of BioHarvest Sciences, said: \"The fourth quarter of 2024 marked another period of strong execution across both our Products and CDMO business units, highlighted by 99% year-over-year revenue growth that consistently exceeded guidance. Our VINIA product lines continued to outper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioharvest-sciences-reports-fourth-quarter-200500707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","BHST","BK4139","BK4183"],"gpt_icon":0},{"id":"2524974387","title":"CVKD: Preparing for Phase 3 Trial of Tecarfarin…","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974387","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974387?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:24","pubTimestamp":1743431040,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics, Inc.  is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant intended to prevent heart attacks, stroke, and death due to blood clots in patients suffering from rare cardiovascular conditions requiring chronic anticoagulation. These conditions include patients with left ventricular assist devices , patients with end-stage kidney disease  and atrial fibrillation , and patients with mechanical heart valves with difficult-to-control time in therapeutic range .The company is currently preparing for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices  trial. Recently, Cardrenal announced a collaboration agreement with Abbott in which Abbott will assist Cadrenal with trial design, site identification, trial awareness, and HeartMate 3 expertise. Abbott is the maker of the HeartMate 3 LVAD, which is the only LVAD currently approved in the U.S.As of December 31, 2024, Cadrenal","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvkd-preparing-phase-3-trial-142400100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","LU1061106388.HKD","BK4504","IE00B2B36J28.USD","LU0234572021.USD","BK4588","IE00BJT1NW94.SGD","BK4183","BK4139","LU2237957902.USD","BK4082","LU1989763427.SGD","IE0009355771.USD","BK4566","BK4581","LU0266013472.USD","SGXZ23171101.USD","LU1691799644.USD","ODD","ABT","LU0122379950.USD","IE0002141913.USD","LU0170899867.USD","CDMO","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1721429741.USD","LU2237957811.SGD","IE00BJJMRZ35.SGD","LU1989763690.USD","LU2133065610.SGD","SG9999002224.SGD","LU2089984988.USD","SG9999002232.USD","LU2468319806.SGD","CVKD","LU1914381329.SGD","LU2112291526.USD","BK4568","LU0868494617.USD","BK4533","SG9999004303.SGD","BK4007","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1721429402.USD"],"gpt_icon":0},{"id":"2523171969","title":"Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523171969","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523171969?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"– FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track – – Enrolling approximately one patient per week across the RESET clinical development program since ACR C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/31/3052139/0/en/Cabaletta-Bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1668664300.SGD","IE00BKVL7J92.USD","LU1989772840.SGD","LU1074936037.SGD","CABA","LU0320765646.SGD","LU0971096721.USD","SLE","LU2347655156.SGD","LU0314104364.USD","LU1989772923.USD","LU0795875086.SGD","LU1720051108.HKD","BK4534","LU0106831901.USD","LU2133065610.SGD","LU0098860793.USD","LU2111349929.HKD","IE00BZ1G4Q59.USD","BK4127","LU0158827781.USD","LU0912757837.SGD","BK4504","LU2089283258.USD","LU0795875169.SGD","LU0158827948.USD","LU1363072403.SGD","LU1162221912.USD","BK4588","LU0267386448.USD","LU2023251221.USD","BK4563","LU1548497426.USD","BK4585","BK4581","LU2089284900.SGD","LU0225283273.USD","LU2271345857.HKD","LU2028103732.USD","IMNM","LU1720051017.SGD","BK4516","LU0006306889.USD","CDMO","LU1732799900.SGD","BK4077","LU2357305700.SGD","LU1732800096.USD","LU0106261372.USD"],"gpt_icon":0},{"id":"2522530276","title":"Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522530276","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522530276?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"Webcast Scheduled for Thursday, April 3 at 4:30 p.m. Eastern. CHASKA, Minn., March 27, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that it will report financial results for the third quarter of fiscal year 2025 on Thursday, April 3, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lifecore-biomedical-report-financial-results-200500244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CFO","BK4121","CDMO","BK4212","LFCR","BK4139"],"gpt_icon":0},{"id":"2522902839","title":"Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522902839","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522902839?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:45","pubTimestamp":1742939100,"startTime":"0","endTime":"0","summary":"New, improved formulation set to replace EGRIFTA SV. MONTREAL, March 25, 2025  -- Theratechnologies Inc.   , a commercial-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration  has approved the Company’s supplemental Biologics License Application  for the F8 formulation of tesamorelin for injection. The Company will commercialize the new formulation under the tradename EGRIFTA WR.Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. The new formulation, EGRIFTA WR, is a daily injectable but only needs weekly reconstitution. It requires less than half the administration volume as the current F4 formulation, sold in the U.S. as EGRIFTA SV, which is reconstituted daily. Pharmacokinetic studies have shown bioequivalence of EGRIFTA WR to the original F1 formulation of tesamorelin for injection .The most commonly reported adverse reactions ofEGRIFTA WR in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/theratechnologies-receives-fda-approval-egrifta-214500945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989771016.USD","LU1941712264.USD","IE00BLSP4452.SGD","LU0965509101.SGD","IE00BJJMRZ35.SGD","LU0203345920.USD","LU1057294990.SGD","LU0006306889.USD","LU1061106388.HKD","LU2324357040.USD","LU1066051498.USD","BK4585","LU2361044949.HKD","LU1934455194.USD","SG9999014559.SGD","LU1934455277.USD","LU1989772840.SGD","BK4550","IE000M9KFDE8.USD","LU2468319806.SGD","SG9999013999.USD","LU1116320737.USD","THTX","LU0265550946.USD","CDMO","IE00BBT3K403.USD","LU1162221912.USD","LU1116320901.HKD","IE0002141913.USD","LU1585245621.USD","IE00B1BXHZ80.USD","MRK","LU2023250504.SGD","IE00BLSP4239.USD","SG9999014542.SGD","LU1929549753.HKD","LU2106854487.HKD","LU2361045086.USD","IE0009355771.USD","IE00BSNM7G36.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU1037948897.HKD","LU2361044865.SGD","LU0985320562.USD","LU1023059063.AUD","LU0965508806.USD","SG9999014575.USD","SG9999001176.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2521288010","title":"OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288010","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288010?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:00","pubTimestamp":1742558400,"startTime":"0","endTime":"0","summary":"OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025:OXB (LSE: OXB) (the \"Company\"), a quality and innovation-led cell and gene therapy CDM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/21/3047023/0/en/OXB-honoured-at-2025-CDMO-Leadership-Awards-in-Cell-Gene-Therapy-Global-category.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2520964769","title":"Press Release: Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520964769","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520964769?lang=en_us&edition=fundamental","pubTime":"2025-03-19 09:30","pubTimestamp":1742347800,"startTime":"0","endTime":"0","summary":"Integer Holdings Corporation Enhances Capitalization Structure with the Closing of $1.0 Billion Convertible Senior Notes Offering. \"This transaction creates revolver capacity to enable us to continue executing our strategy while reducing our interest costs by meaningfully increasing the percentage of our debt at substantially lower interest rates,\" said Joe Dziedzic, president and CEO. \"We believe the strong demand from investors for this convertible bond offering demonstrates investors' confidence in Integer's strategy and financial strength.\". Upon conversion, the principal amount of the Notes will be paid in cash. As a result of the related capped call transactions, dilution upon a conversion of the Notes will be mitigated by the increased effective conversion price of the Notes to $189.44, a premi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU0566484027.USD","LU1815336091.USD","LU1169589451.USD","BK4232","BK4022","LU1169590202.USD","R","LU0128526141.USD","LU1559883803.SGD","ITGR","BK4082","LU0757428866.USD","LU0029874061.USD","BK4139"],"gpt_icon":0},{"id":"2520331549","title":"Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2520331549","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520331549?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209200,"startTime":"0","endTime":"0","summary":"Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure . Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch. CHASKA, Minn. and MINNEAPOLIS, March 17, 2025  -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , and Humanetics Corporation , an advanced clinical-stage pharmaceutical company, today announced that Humanetics has selected Lifecore to provide a range of CDMO services to support the continued development of BIO 300 for the prevention of acute radiation syndrome. Under the terms of the agreement, Lifecore will conduct technology transfer of the existing fill and finish process for BIO 300, including formulation development, gap assessment, and filling of a pilot batch. Lifecore will also undertake analytical method work including feasibility assessments designed to estimate future development work for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humanetics-selects-lifecore-biomedical-deliver-110000609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDMO","BK4121","BK4585","BK4139","LFCR","LU1169589451.USD","BK4588","CFO","BIO","BK4212","LU1169590202.USD"],"gpt_icon":0},{"id":"2520602335","title":"Samsung Biologics Likely to Benefit From Rising CDMO Penetration -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2520602335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520602335?lang=en_us&edition=fundamental","pubTime":"2025-03-17 15:28","pubTimestamp":1742196480,"startTime":"0","endTime":"0","summary":"0728 GMT - Samsung Biologics is likely to benefit from rising contract development and manufacturing organization penetration, Nomura's analyst Cindy Park says in a research report. Nomura's view is partly based on strong global demand for large-scale contract manufacturing organizations, as pharmaceutical firms are increasingly transitioning into CDMOs to minimize risks related to high capex and uncertainties on drug approvals. CDMO penetration in global bio-pharmaceutical industry for mammalian cells will likely rise to 45% by 2030 from estimated 35% this year, with the South Korean contract development and manufacturing organization likely to be a key beneficiary. Nomura assumes coverage of the stock with a buy rating and a target price of KRW1,400,000.00. It previously held a neutral rating and a target price of KRW840,000.00. Shares closed 1.7% higher at KRW1,069,000.00. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2519581438","title":"Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2519581438","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519581438?lang=en_us&edition=fundamental","pubTime":"2025-03-14 11:29","pubTimestamp":1741922940,"startTime":"0","endTime":"0","summary":"PLANO, Texas, March  13, 2025  (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $875.0 million aggregate princ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042725/26755/en/Integer-Holdings-Corporation-Announces-Upsize-and-Pricing-of-Convertible-Notes-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4139","LU0029874061.USD","LU0128526141.USD","LU1169589451.USD","LU1169590202.USD","ITGR","CDMO","LU0757428866.USD","BK4082","LU1815336091.USD","LU0566484027.USD"],"gpt_icon":0},{"id":"2519695478","title":"Press Release: Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin","url":"https://stock-news.laohu8.com/highlight/detail?id=2519695478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519695478?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:05","pubTimestamp":1741896300,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Reports Full Year 2024 Results, Business Highlights, and Path Forward for Clinical Advancement of Tecarfarin. Recent Collaboration Agreement with Abbott Global Enterprises Limited  in support of Phase 3 randomized, multicenter study, entitled TECH-LVAD. Recent FDA Type D Meeting provides additional guidance for advancing clinical development of tecarfarin. Cadrenal Therapeutics, Inc. , a biopharmaceutical company focused on the development of tecarfarin, a new Phase 3 ready oral vitamin K antagonist, today reported full year results for the period ended December 31, 2024, and provided a business update and highlights of the path forward for the clinical advancement of tecarfarin.Full Year 2024 Key Accomplishments and Recent Highlights. Cadrenal appointed James J. Ferguson, MD, FACC, FAHA, as Chief Medical Officer to lead the late-stage clinical development of tecarfarin and other indications in rare cardiovascular conditions requiring life-long anticoagulation the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4504","LU1691799644.USD","LU1057294990.SGD","IE0009355771.USD","LU0122379950.USD","BK4183","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2089984988.USD","SGXZ23171101.USD","BK4585","IE00BJT1NW94.SGD","LU2133065610.SGD","BK4604","LU1721429741.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1989763427.SGD","SG9999004303.SGD","LU0170899867.USD","SG9999002232.USD","LU1061106388.HKD","LENZ","ABT","ODD","BK4588","LU2112291526.USD","BK4533","BK4566","LU1989763690.USD","FORD","IE00BFTCPJ56.SGD","03160","BK4139","LU1721429402.USD","TM","LU0868494617.USD","LU0266013472.USD","LU2237957902.USD","LU2237957811.SGD","LU0234572021.USD","LU1914381329.SGD","BK4581","BK4592","BK4007","BK4082","CDMO","CVKD","SG9999002224.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":176,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.249997,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2020-04-24","current":-55.197032,"twenty":-58.357168,"median":-6.237055,"eighty":-2.504068,"marketCap":295966486},{"date":"2020-05-01","current":-64.782776,"twenty":-65.583344,"median":-6.237055,"eighty":-2.504068,"marketCap":347365247},{"date":"2020-05-08","current":-66.994871,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":359226499},{"date":"2020-05-15","current":-58.462505,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":313475954},{"date":"2020-05-22","current":-55.723721,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":298790594},{"date":"2020-05-29","current":-61.517303,"twenty":-66.904816,"median":-6.237055,"eighty":-2.504068,"marketCap":329855779},{"date":"2020-06-05","current":-67.942912,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":364309893},{"date":"2020-06-12","current":-60.463924,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":324207563},{"date":"2020-06-19","current":-59.305208,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":317994527},{"date":"2020-06-26","current":-62.465344,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":334939173},{"date":"2020-07-02","current":-38.876487,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":406881316},{"date":"2020-07-10","current":-37.526609,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":392753493},{"date":"2020-07-17","current":-40.523339,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":424117261},{"date":"2020-07-24","current":-36.662687,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":383711686},{"date":"2020-07-31","current":-40.06438,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":419313801},{"date":"2020-08-07","current":-41.738229,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":436832302},{"date":"2020-08-14","current":-45.841858,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":479780886},{"date":"2020-08-21","current":-45.031931,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":471304191},{"date":"2020-08-28","current":-45.916081,"twenty":-67.634265,"median":-6.237055,"eighty":-2.504068,"marketCap":480557704},{"date":"2020-09-04","current":-149.319573,"twenty":-67.942912,"median":-6.237055,"eighty":-2.504068,"marketCap":384049943},{"date":"2020-09-11","current":-158.01246,"twenty":-68.84612,"median":-6.237055,"eighty":-2.504068,"marketCap":406408046},{"date":"2020-09-18","current":-174.517939,"twenty":-69.166335,"median":-6.273961,"eighty":-2.504068,"marketCap":448860140},{"date":"2020-09-25","current":-165.054798,"twenty":-69.619972,"median":-6.314377,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-02","current":-165.054798,"twenty":-70.073609,"median":-6.352234,"eighty":-2.504068,"marketCap":424520940},{"date":"2020-10-09","current":-176.938743,"twenty":-70.407166,"median":-6.396225,"eighty":-2.504068,"marketCap":455086447},{"date":"2020-10-16","current":-176.278524,"twenty":-70.847461,"median":-6.421583,"eighty":-2.504068,"marketCap":453388363},{"date":"2020-10-23","current":-180.459912,"twenty":-71.381152,"median":-6.5323,"eighty":-2.504068,"marketCap":464142894},{"date":"2020-10-30","current":-159.552971,"twenty":-71.701366,"median":-6.587659,"eighty":-2.504068,"marketCap":410370242},{"date":"2020-11-06","current":-183.761008,"twenty":-72.235057,"median":-6.662048,"eighty":-2.504068,"marketCap":472633313},{"date":"2020-11-13","current":-196.305173,"twenty":-73.622653,"median":-6.679923,"eighty":-2.504068,"marketCap":504896904},{"date":"2020-11-20","current":-197.845684,"twenty":-75.073301,"median":-6.772187,"eighty":-2.504068,"marketCap":508859100},{"date":"2020-11-27","current":-196.745319,"twenty":-76.904852,"median":-6.782203,"eighty":-2.504068,"marketCap":506028960},{"date":"2020-12-04","current":4498.158592,"twenty":-77.30512,"median":-6.772187,"eighty":-2.483106,"marketCap":638738520},{"date":"2020-12-11","current":4438.917085,"twenty":-77.30512,"median":-6.716829,"eighty":-2.406889,"marketCap":630326226},{"date":"2020-12-18","current":4853.303049,"twenty":-77.30512,"median":-6.716829,"eighty":-2.282345,"marketCap":689169033},{"date":"2020-12-24","current":4857.56781,"twenty":-77.30512,"median":-6.716829,"eighty":-2.161884,"marketCap":689774629},{"date":"2020-12-31","current":4921.539296,"twenty":-77.30512,"median":-6.716829,"eighty":-2.109644,"marketCap":698858580},{"date":"2021-01-08","current":5608.166528,"twenty":-77.30512,"median":-6.716829,"eighty":-2.071578,"marketCap":796359647},{"date":"2021-01-15","current":5770.227613,"twenty":-77.30512,"median":-6.716829,"eighty":-2.052613,"marketCap":819372321},{"date":"2021-01-22","current":6077.290725,"twenty":-77.30512,"median":-6.716829,"eighty":-2.039121,"marketCap":862975283},{"date":"2021-01-29","current":6222.292746,"twenty":-77.30512,"median":-6.716829,"eighty":-2.028206,"marketCap":883565570},{"date":"2021-02-05","current":7774.667359,"twenty":-77.30512,"median":-6.716829,"eighty":-2.00864,"marketCap":1104002765},{"date":"2021-02-12","current":7642.459634,"twenty":-77.30512,"median":-6.716829,"eighty":-1.981915,"marketCap":1085229268},{"date":"2021-02-19","current":7616.871042,"twenty":-77.30512,"median":-6.716829,"eighty":-1.967528,"marketCap":1081595688},{"date":"2021-02-26","current":8776.887239,"twenty":-77.30512,"median":-6.716829,"eighty":-1.953306,"marketCap":1246317988},{"date":"2021-03-05","current":7574.223387,"twenty":-77.331805,"median":-6.744508,"eighty":-1.945514,"marketCap":1075539721},{"date":"2021-03-12","current":236.593569,"twenty":-77.331805,"median":-6.744508,"eighty":-1.937875,"marketCap":1053551161},{"date":"2021-03-19","current":246.292266,"twenty":-77.331805,"median":-6.744508,"eighty":-1.928906,"marketCap":1096739459},{"date":"2021-03-26","current":230.173304,"twenty":-77.278436,"median":-6.698376,"eighty":-1.924277,"marketCap":1024961724},{"date":"2021-04-01","current":262.001423,"twenty":-77.278436,"median":-6.698376,"eighty":-1.907206,"marketCap":1166692337},{"date":"2021-04-09","current":264.870052,"twenty":-77.30512,"median":-6.716829,"eighty":-1.906724,"marketCap":1179466340},{"date":"2021-04-16","current":261.72822,"twenty":-77.30512,"median":-6.716829,"eighty":-1.903436,"marketCap":1165475765},{"date":"2021-04-23","current":289.594899,"twenty":-77.30512,"median":-6.716829,"eighty":-1.897813,"marketCap":1289566086},{"date":"2021-04-30","current":292.395227,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1302035947},{"date":"2021-05-07","current":277.300776,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1234820356},{"date":"2021-05-14","current":274.432148,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1222046353},{"date":"2021-05-21","current":274.295546,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888362,"marketCap":1221438067},{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1745039249551}}}